Details for New Drug Application (NDA): 019805
NDA 019805 describes HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by B Braun and Hospira and is included in four NDAs. It is available from two suppliers. Additional details are available on the HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER profile page.
The generic ingredient in HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER is heparin sodium. There is one drug master file entry for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
The generic ingredient in HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER is heparin sodium. There is one drug master file entry for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for 019805
| Tradename: | HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER |
| Applicant: | Hospira |
| Ingredient: | heparin sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 4,000 UNITS/100ML | ||||
| Approval Date: | Jan 25, 1989 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5,000 UNITS/100ML | ||||
| Approval Date: | Jan 25, 1989 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
